lifenews.com
2025-05-03
The Washington Stand reported in detail on Monday on a massive new study of U.S. women who have consumed the abortion pill. The study is the first in a planned series from the Ethics and Public Policy Center (EPPC), a Washington, D.C.-based nonprofit that describes itself as "the premier institute working to apply the riches of the Jewish and Christian traditions to contemporary questions of law, culture, and politics, in pursuit of America's continued civic and cultural renewal."
The study of nearly 866,000 abortions procured by use of the prescription drug mifepristone is the largest of its kind to date and full of findings that, its authors say, should prompt action by the U.S. Food and Drug Administration (FDA) to review and address the high rate of serious complications the drug inflicts on women.
The study is significant in many ways in addition to the size of the study population. First, it covers a sample of women who have taken the drug in recent years, whereas prior safety and efficacy studies date back a decade or more. The EPPC study examined the impact of the drug under the loose conditions that have actually prevailed in the past decade. These conditions, as prior investigators have warned, include deletion of multiple medical visits originally recommend by the FDA, the use of "no test" protocols designed to confirm pregnancy and to assure it is not ectopic, online distribution of the pills, and use for at least three and sometimes more weeks later in pregnancy than when the drug was originally approved in the year 2000. Mifepristone is known to become less effective and more hazardous for women as the pregnancy proceeds.